- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Westbrook Today
By the People, for the People
IDEXX Laboratories Releases FY 2026 Earnings Guidance
Animal health company forecasts revenue and earnings for the upcoming fiscal year
Feb. 2, 2026 at 9:55am
Got story updates? Submit your updates here. ›
IDEXX Laboratories (NASDAQ:IDXX), a global provider of diagnostic products and services for the animal health, water testing, and food safety markets, has issued its fiscal year 2026 earnings guidance. The company expects earnings per share in the range of $14.29 to $14.80 and revenue between $4.6 billion and $4.7 billion for the upcoming year.
Why it matters
IDEXX's earnings guidance provides insight into the company's financial performance and growth outlook, which is closely watched by investors and analysts. As a leading player in the animal health diagnostics market, IDEXX's results are seen as a barometer for the broader industry.
The details
IDEXX's FY 2026 earnings guidance came in slightly below the current consensus estimates of $14.45 per share in earnings and $4.7 billion in revenue. The company cited continued demand for its in-clinic diagnostic instruments, consumables, reference laboratory testing, and practice-management tools as drivers of its projected growth.
- IDEXX Laboratories issued the FY 2026 earnings guidance on Monday, February 2, 2026.
The players
IDEXX Laboratories
A global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets, headquartered in Westbrook, Maine.
The takeaway
IDEXX Laboratories' FY 2026 earnings guidance suggests the company expects continued strong demand for its animal health diagnostic products and services, underscoring the growth potential in this market as pet ownership and veterinary care trends remain favorable.
